Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

Fig. 5

RAMRIS parameters. Adjusted mean change from baseline and unadjusted box and whisker plot of unadjusted change from baseline by treatment over time. a Synovitis. b Bone erosion. c Osteitis (combined b.i.d. and t.i.d. dosing). d Cumulative plot probability of change from baseline in bone erosion total score on day 85. b.i.d., twice daily; RAMRIS, Rheumatoid Arthritis MRI Scoring System; t.i.d., three times daily

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us